Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Kennedy, A. L. et al.
BioRxiv (2020)

Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with predisposition to developing leukemia. We found that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53. EIF6 mutations cause functional compensation for the germline deficiency by alleviating the SDS ribosome joining defect, improving translation, and reducing p53 activation. TP53 mutations decrease checkpoint activation without affecting ribosome assembly. We link development of leukemia with acquisition of biallelic TP53 alterations. Our results define distinct pathways of clonal selection driven by germline fitness constraint and provide a mechanistic framework for clinical surveillance.


Kennedy, A. L., Myers, K. C., Bowman, J., Gibson, C. J., Camarda, N. D., Furutani, E. M., Muscato, G. M., Klein, R. H., Ballotti, K., Liu, S., Harris, C. E., Galvin, A., Malsch, M., Dale, D., Gansner, J. M., Nakano, T. A., Bertuch, A., Vlachos, A., Lipton, J. M., Castillo, P., Connelly, J., Churpek, J., Edwards, J. R., Hijiya, N., Ho, R. H., Hofmann, I., Huang, J. N., Keel, S., Lamble, A., Lau, B. W., Norkin, M., Stieglitz, E., Stock, W., Walkovich, K., Boettcher, S., Brendel, C., Fleming, M. D., Davies, S. M., Weller, E. A., Bahl, C., Carter, S. L., Shimamura, A., Lindsley, R. C.


A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN.
Xiao, Wenbin
Blood Advances (2020)
Single-cell mutation analysis of clonal evolution in myeloid malignancies.
Miles, L. A.
Nature (2020)
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Wang, F.
BioRxiv (2020)
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis
Laura W. Dillon
MedRxiv (2020)